Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in RPRX — Royalty Pharma plc

CIK 923093 STAMFORD, CT

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$34,243,967
+$2,023,478 QoQ
Shares Held
610,736
-9.1% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#79
of 646 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Derivatives in RPRX

reported options exposure · as of Mar 31, 2026
CallValue
$2,168,244
CallShares
45,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $414,135,114 across 107 Biotechnology names. RPRX ranks #2 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 RPRX
Royalty Pharma plc
This page
610,736 $34,243,967

All Filings in RPRX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,243,967 610,736
2026-03-31 $32,220,489 671,680
2026-03-31 $2,168,244 45,200
2025-12-31 $35,735,006 924,819
2025-09-30 $30,476,098 863,835
2025-06-30 $23,157,778 642,736
2025-03-31 $22,654,421 727,736
2024-12-31 $18,750,538 735,027
2024-09-30 $14,392,622 508,753
2024-06-30 $8,240,625 312,500
2024-03-31 $487,377 16,048
2023-12-31 $1,988,491 70,790
2023-09-30 $5,668,813 208,873
2023-06-30 $1,873,295 60,940